Varicella Vaccination for a 44-Year-Old Male Without Prior Chickenpox
A 44-year-old male who has never had chickenpox should receive the two-dose varicella vaccine series to prevent potentially severe disease and complications. 1
Rationale for Vaccination
Adults without a history of chickenpox are at higher risk for severe disease complications if they contract varicella. Key considerations include:
- Adults typically experience more severe primary varicella disease than children 2
- Complications such as secondary bacterial infection, pneumonitis, and encephalitis occur in approximately 1% of cases 3
- The two-dose vaccine series provides optimal protection with 98.3% efficacy compared to 85% with a single dose 1
Vaccination Protocol
- Dosage and Schedule: Two 0.5-mL doses of single-antigen varicella vaccine administered subcutaneously, 4-8 weeks apart 1
- Administration: Given subcutaneously in the outer aspect of the upper arm
- Efficacy: The two-dose regimen provides 98.3% protection against varicella 1
Special Considerations
Pre-Vaccination Assessment
- Verify absence of contraindications:
Post-Vaccination Guidance
- Breakthrough varicella after vaccination is typically milder with fewer lesions 1
- No booster doses are currently recommended beyond the two-dose series 1
Potential Benefits Beyond Individual Protection
- Contributes to community immunity, helping prevent outbreaks in congregate settings 1
- May potentially reduce the risk of herpes zoster (shingles) later in life 5
- Prevents transmission to vulnerable populations, including immunocompromised individuals and pregnant women 1
Common Pitfalls to Avoid
Misconception: Assuming adults don't need vaccination against "childhood diseases"
- Reality: Varicella is often more severe in adults than in children 2
Misconception: Serologic testing is necessary before vaccination
- Reality: Serologic testing is generally neither necessary nor recommended before vaccination for those without evidence of immunity 1
Misconception: Single-dose vaccination is sufficient
- Reality: Two doses are recommended for adults to achieve optimal protection (98.3% vs. 85% efficacy) 1
The CDC, Advisory Committee on Immunization Practices (ACIP), and American Academy of Pediatrics all support this recommendation for susceptible adults, particularly those in high-risk categories such as healthcare workers, teachers, college students, and adults living in households with children 1.